Glenn Greenberg recent buys & sells (2014 Q4)
Brave Warrior Advisors
Brave Warrior Advisors Portfolio Changes
Purchase & sale details
- Portfolio value:
- $2.87B (+$174M)
- Previous value:
- $2.70B
- # of changes:
- 13
- New positions:
- 4
- Reported for:
- 31 Dec 2014 (Q4)
- Latest filing date:
- 17 Feb 2015
Brave Warrior Advisors has disclosed a total of 13 changes to the portfolio in the (2014 Q4) SEC report(s): increased the number of shares of 4, bought 4 totally new, decreased the number of shares of 3 and completely sold out 2 position(s).
What stocks did Glenn Greenberg buy in 2014 Q4?
During 2014 Q4 Glenn Greenberg has bought 8 securities out of which top 5 purchases (by % change to portfolio) were (JPM) JPMorgan Chase & Co (added shares +14.31%), (SCHW) Charles Schwab Corp (added shares +1.57%), (MSFT) Microsoft Corp (added shares +5.92%), (CMPR) CIMPRESS NV (new buy) and (EQIX) Equinix Inc (added shares +17.28%).
What did Glenn Greenberg invest in during 2014 Q4?
In the 2014 Q4 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (reduced shares -6.98%), (ESRX) Express Scripts Holding Co (reduced shares -17.94%), (JPM) JPMorgan Chase & Co (added shares +14.31%), (SCHW) Charles Schwab Corp (added shares +1.57%) and (MSFT) Microsoft Corp (added shares +5.92%).
13 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Baker Hughes Inc
|
new
|
$56.07
|
|
0.70%
|
2014 Q4
|
~0.25 years
|
||||
|
|
CIMPRESS NV
|
new
|
$74.84
|
+1.10%($75.66)
|
7.38%
|
2014 Q4
|
~0.25 years
|
||||
|
|
Halliburton Company
|
new
|
$39.33
|
-17.06%($32.62)
|
5.67%
|
2014 Q4
|
~0.25 years
|
||||
|
|
Kinder Morgan Inc
|
new
|
$42.31
|
-21.05%($33.40)
|
6.18%
|
2014 Q4
|
~0.25 years
|
||||
|
|
Equinix Inc
|
+17.28%
|
$219.91
|
+342.57%($973.27)
|
6.73%
|
2014 Q2
|
~0.75 years
|
||||
|
|
JPMorgan Chase & Co
|
+14.31%
|
$62.58
|
+436.94%($336.02)
|
9.07%
|
2014 Q3
|
~0.50 years
|
||||
|
|
Microsoft Corp
|
+5.92%
|
$46.45
|
+1,049.40%($533.90)
|
8.28%
|
2013 Q3
|
~1.50 years
|
||||
|
|
Charles Schwab Corp
|
+1.57%
|
$30.19
|
+198.33%($90.06)
|
8.91%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
-6.98%
|
$143.11
|
|
30.53%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Express Scripts Holding Co
|
-17.94%
|
$84.67
|
|
12.05%
|
2013 Q2*
|
> 1 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".